Skip to content

Study on Clinical Effectiveness and Safety of Chuna Manual Therapy Combined with Acupuncture and Cupping for Frozen Shoulder(Adhesive Capsulitis)

Study on Clinical Effectiveness and Safety of Chuna Manual Therapy Combined with Acupuncture and Cupping for Frozen Shoulder(Adhesive Capsulitis); a multicenter, randomized, patient-assessor blind, clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002300
Enrollment
66
Registered
2017-04-06
Start date
2017-06-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery, Others : Participants who met the inclusion criteria are randomised to one of two parallel groups. Participants in the experimental group receive acupuncture, cuppin

Sponsors

Wonkwang University, Gwangju Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females aged 25 to 65 years old, one side-shoulder pain for 6 weeks to 12 months, with a significant pain of visual analogue scale(VAS) 50mm-100mm, with more than 25% limitation of motion of range in two or more movements compared to the unilateral side, who can be diagnosed as frozen shoulder (adhesion capsulitis) by excluding simple fracture, dislocation, degenerative arthropathy, and calcific tendinitis in plain radiography. 2) Those who have minimal help with the nature of the pain and are able to communicate sufficiently with the researcher and write a questionnaire. 3) Those who have pledged not to receive treatment other than the prescribed treatment within the period of study. 4) Agreed with written informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1) History of major shoulder injury or surgery 2) Patients with disorders of the cervical spine or other upper extremity that has a significant impact on the shoulder 3) Patients who complain of shoulder pain accompanied by stroke, spinal cord injury, or other surgery 4) Patients with fracture, dislocation, degenerative arthropathy and calcific tendinitis of the shoulder in plain radiography 5) Patients with positive findings in physical examination(drop arm test, empty can test) for exclusion of rotator cuff tear 6) ALT(SGPT), AST (SGOT) measured at a screening visit is greater than twice the normal upper limit (ULN) 7) Serum creatinine and BUN (blood urea nitrogen) measured at a screening visit is greater than twice the normal upper limit (ULN) 8) Patients with concomitant disorders contraindicated to Acetaminophen or hypersensitivity to Acetaminophen(Acetaminophen is relief medication in this study) 9) Pregnant or breastfeeding patients 10) Patients who are taking medicines after being diagnosed with mental disorders 11) Patients with all other joint diseases that are associated with musculoskeletal disorders that may affect efficacy assessment, or that are considered to be unacceptable for this trial (eg. septic arthritis, inflammatory joint disease, gout, recurrent pseudogout, Paget's disease, joint fracture, exogenous ochronosis, acromegaly, hematochromatosis, Wilson's disease, primary osteochondrosis, hereditary disorder(eg. hyperkinetic), collagen gene abnormality, etc.) 12) Patients who were considered as unsuitable for participation by the researcher

Design outcomes

Primary

MeasureTime frame
Shoulder pain and disability index(SPADI)

Secondary

MeasureTime frame
Quality of life scales(Rotator cuff quality of life, EuroQoL-5 Dimensions);Amount and frequency of relief medicine(Acetaminophen);100mm Visual analogue scale(VAS) of shoulder pain;Passive range of motion(ROM) of shoulder ;Korean shoulder scoring system(KSS) ;Patient's satisfaction;Cost-effectiveness

Countries

Korea, Republic of

Contacts

Public ContactSeung ryong Yeom

Wonkwang University, Gwangju Medical Center

windy2589@hanmail.net+82-62-670-6460

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026